Prolaktin a systémový lupus erythematodes
Prolactin And Systemic lupus erythematosus
dissertation thesis (DEFENDED)

View/ Open
Permanent link
http://hdl.handle.net/20.500.11956/11351Identifiers
Study Information System: 133286
Collections
- Kvalifikační práce [4588]
Author
Advisor
Referee
Pokorný, Jaroslav
Hrnčíř, Zbyněk
Faculty / Institute
First Faculty of Medicine
Discipline
-
Department
Department of Rheumatology First Faculty of Medicine and Rheumatology Institute
Date of defense
14. 6. 2007
Publisher
Univerzita Karlova, 1. lékařská fakultaLanguage
Czech
Grade
Pass
Prolactin (PRL) is a polypeptide hormone of 23 kDa molecular weight made up of 199 amino acids, and produced by lactotropes, acidophilic cells of the anterior lobe of the pituitary. PRL is also synthetized in some other parts of the brain and in certain peripheral blood elements. Whether this extra-pituitary PRL, also known as PRL-like hormone, interferes with serum PRL radioimmunoassay (RIA) and whether it also has a feedback effect on PRL secretion in the pituitary, has yet to be elucidated. There is, however, proof of its apocrine and paracrine function of cellular growth factor, a function enhancing mitogenesis and lymphocyte differentiation at the site of inflammation and thereby their own production of yet other mediators and immunomodulators - including interleukines (IL) and growth factors. PRL also directly interferes with the synthesis of some acute-phase proteins in the liver (stimulating, e.g., alpha-2-macroglobulin synthesis). As a result of these discoveries, PRL was classed among immunomodulators, and the hypothesis was advanced of its part in the pathogenesis of autoimmune diseases. The aim of the thesis was to verify the presence of hyperprolactinemia (hyper- PRL) in SLE patients compare to patients with other auto-immune diseases and to healthy controls and to find its association...